Regulatory Perspectives – Emerging Approaches in Dermatology Drug Development

Time: 8:30 am
day: Day Two

Details:

  • Addressing the utilization of digital tools in dermatology clinical trials
  • Demonstrating efficacy in Hidradenitis suppurativa – exploring clinical endpoints, new scoring systems and clinical trial design considerations in HS

Speakers: